Ethnicity and psychopharmacology in Latin America

Mount Sinai Journal of Medicine

Volumn 63, Issue 5-6, 1996, Pages 330-331

  Ramirez, Luis F ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; NORTRIPTYLINE; RISPERIDONE;

ETHNOLOGY; HUMAN; PHARMACODYNAMICS; PHARMACOKINETICS; PSYCHOPHARMACOLOGY; SHORT SURVEY; SOUTH AND CENTRAL AMERICA;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; ETHNIC GROUPS; HUMANS; LATIN AMERICA; PSYCHOTROPIC DRUGS; SCHIZOPHRENIA;

EID: 0029806991     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. Lin K-M, Anderson D, Poland RE. Ethnicity and psychopharmacology. Psychiatr Clin North Am 1995; 18:3.
2. Potkin SG, Shen Y, Pardes H, et al. Haloperidol concentrations elevated in Chinese patients. Psychiatr Res 1984; 12:167-172.
3. Gaviria MA, Gill AA, Javaid JI. Nortriptyline kinetics in Hispanic and Anglo subjects. J Clin Psychopharmacol 1986; 6:227-231.
4. Leon CA. Therapeutic effects of clozapine. A 4-year follow-up of a controlled clinical trial. Acta Psychiatr Scand 1979; 59:471-480.
5. Potkin SG, Bera R, Gulasekaram B, et al. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. J Clin Psychiatry 1994; 55:133-137.
6. Meltzer HY, Alphs L, Bastani B, et al. One year outcome of study of clozapine in treatment resistant schizophrenia. Presented at 8th World Congress of Psychiatry; Athens; October 13-19, 1989: 19-27.
7. Escobar J, Tuason V. Antidepression agents: A cross cultural study. Psychopharmacol Bull 1980; 16:49-52.
8. Jablensky A, Sartorious N, Emberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992: 20